Hamilton BioVentures
VC Fund
Solana Beach, United States
Hamilton BioVentures is a venture capital firm (with $100 million under management) investing in talented entrepreneurs bringing new Life Science technology enterprises to market. Hamilton BioVentures invests in companies developing dramatically better treatments (biopharmaceuticals and medical devices) for major human diseases and other medicalconditions. Their investments generally take the form of direct equity in early-stage companies located on the West Coast.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Hamilton BioVentures invests in
Stages Hamilton BioVentures invests in
Countries Hamilton BioVentures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anita Minard
|
|||
Ann Collins
|
|||
D.Elliot Parks
|
|||
Ellen Smock
|
|||
Elliot Parks
|
Investment Focus
Industry
- Biotechnology 4 (80%)
- Pharmaceutical 3 (60%)
- Therapeutics 2 (40%)
- Software 1 (20%)
- Health Care 1 (20%)
Stage
- Series C 3 (60%)
- Series B 1 (20%)
- Series D 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Anita Minard
Administrative Controller
|
Administrative Controller | Total investments: 0 | Find email | |
|
Ann Collins
Controller
|
Controller | Total investments: 0 | Find email | |
|
D.Elliot Parks
Director
|
Director | Total investments: 1 | Find email | |
|
Ellen Smock
Administrative Manager
|
Administrative Manager | Total investments: 0 | Find email | |
|
Elliot Parks
Director
|
Director | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ceregene
|
Ceregene is a private, San Diego-based biotechnology company focused on the treatment of major neurodegenerative disorders using the delivery of nervous system growth factors. Their clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor, which is about to enter Phase 2 studies for the treatment of Alzheimer'sdisease, and CERE-120, which recently completed a Phase 2 trial in Parkinson's disease and is currently being evaluated for future development. CERE-135 and CERE-140 are in preclinical development for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and ocular diseases, respectively. | $28M / Series C / Jun 22, 2007 | |
Transcept Pharmaceuticals
|
Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company's first institutional round of funding alongside Montreaux EquityPartners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates. | $40M / Series D / Mar 08, 2007 | |
Kemia
|
Kémia operates as a pharmaceutical company. The company discovers and develops small molecule therapeutics. It offers allosteric kinase inhibitors for the treatment of inflammatory diseases, such as rheumatoid arthritis, as well as for cardiovascular and metabolic conditions; and modulators of G protein-coupled receptors. The company specializes inthe fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development. | $31M / Series C / Aug 23, 2006 | |
PhotoThera
|
PhotoThera is currently hiring for the following positions: Sr. Software Engineer Mechanical Engineer Configuration Management Engineer Sr. Electrical Engineer Send your resume and cover letter to ktitano@photothera.com, or go to www.photothera.com for further information.Specialtieslaser, medical device, eschemic, stroke,infrared | $30.5M / Series C / Apr 21, 2006 | |
Troika Networks
|
Troika Networks, Inc. provides storage network data protection and management integrated solutions, hosting platforms, and enabling technologies. Its integrated solutions, application hosting platforms, and embedded technology provide a cost-effective approach for implementing disaster recovery, backup, and volume management functionality throughoriginal equipment manufacturers and resellers worldwide. The company was founded in 1998 and is based in Westlake Village, California. | $14.4M / Series B / Jul 14, 2005 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Hamilton BioVentures invest in?
Hamilton BioVentures invests primarily in Biotechnology, Pharmaceutical and Therapeutics startups, most often at Series C and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Hamilton BioVentures?
Public channels for Hamilton BioVentures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Hamilton BioVentures?
The team at Hamilton BioVentures includes Anita Minard (Administrative Controller), Ann Collins (Controller) and D.Elliot Parks (Director), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
